Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-17

FDA Approved: AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals' original application for a fixed-dose combination generic of amlodipine besylate and olmesartan medoxomil. The product is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)
  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL (AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL)